Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Urien

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Cancer Chemotherapy and Pharmacology|January 29, 2019
Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOPE Baudry, S Huguet, A L Couderc, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysisV Jullien, A Raïs, S Urien, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
International Journal of Tissue Reactions|January 1, 1993
Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicityE Albengres, S Urien, J Barre, et al.
Cancer Chemotherapy and Pharmacology|November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over studyE G C Brain, K Rezai, S Weill, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2014
Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancerZ Daher Abdi, S Lavau-Denes, A Prémaud, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapyH Rubie, F Doz, G Vassal, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosisT Trenque, N Simon, I Villena, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamideN Germann, S Urien, Andrew H Rodgers, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]C Dariane, A Amin, O Lortholary, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 29, 2019
Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOPE Baudry, S Huguet, A L Couderc, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysisV Jullien, A Raïs, S Urien, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
International Journal of Tissue Reactions|January 1, 1993
Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicityE Albengres, S Urien, J Barre, et al.
Cancer Chemotherapy and Pharmacology|November 16, 2006
Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over studyE G C Brain, K Rezai, S Weill, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2014
Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancerZ Daher Abdi, S Lavau-Denes, A Prémaud, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapyH Rubie, F Doz, G Vassal, et al.
British Journal of Clinical Pharmacology|May 21, 2004
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosisT Trenque, N Simon, I Villena, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamideN Germann, S Urien, Andrew H Rodgers, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]C Dariane, A Amin, O Lortholary, et al.
Pageof 13